Microbot Medical Inc is an innovative medical technology company dedicated to advancing minimally invasive surgical procedures through the development of its proprietary Microbot platform
The company focuses on creating a new category of robotic-assisted medical devices aimed at improving patient outcomes and enhancing the overall surgical experience. By leveraging cutting-edge robotics and engineering, Microbot Medical innovates solutions that can be applied across various surgical specialties, promoting precision, efficiency, and safety in complex medical procedures. Their commitment to research and development positions them as a leader in transforming the landscape of medical interventions.
Microbot Medical shares are trading higher by 33% during Monday's session. The company is raising $7 million through stock sales and investment options.
Microbot Medical shares are trading higher Monday after the company announced that it has received FDA approval to proceed with its human clinical trial as part of its Investigational Device Exemption (IDE) application for its LIBERTY Endovascular Robotic Surgical System.
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 50 points on Friday. The Dow traded down 0.17% to 37,644.68 while the NASDAQ fell 0.48% to 15,022.70. The S&P 500 also fell, dropping, 0.33% to 4,767.78.
